These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38968386)

  • 1. Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic.
    Weas S; Pawlowski K; Miller M; DePillis R; Baumer N
    J Child Adolesc Psychopharmacol; 2024 Jul; ():. PubMed ID: 38968386
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children.
    Heuvelman H; Davies NM; Ben-Shlomo Y; Emond A; Evans J; Gunnell D; Liebling R; Morris R; Payne R; Storey C; Viner M; Rai D
    Health Technol Assess; 2023 Sep; 27(15):1-83. PubMed ID: 37842916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurring conditions in Down syndrome: Findings from a clinical database.
    Baumer NT; Hojlo MA; Pawlowski KG; Milliken AL; Lombardo AM; Sargado S; Soccorso C; Davidson EJ; Barbaresi WJ
    Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32072. PubMed ID: 37873945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
    Dominick KC; Andrews HF; Kaufmann WE; Berry-Kravis E; Erickson CA
    J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):659-669. PubMed ID: 34818076
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study.
    Cosme CG; Rudig NO; Borsellino PJ; Chea D; Krider RI; Durette L
    Front Psychiatry; 2023; 14():1278233. PubMed ID: 38274418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurring conditions in children with Down syndrome and autism: a retrospective study.
    Spinazzi NA; Santoro JD; Pawlowski K; Anzueto G; Howe YJ; Patel LR; Baumer NT
    J Neurodev Disord; 2023 Mar; 15(1):9. PubMed ID: 36864370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
    Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
    J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit.
    Perera B; Chen J; Korb L; Borakati A; Courtenay K; Henley W; Tromans S; Shankar R
    Expert Opin Pharmacother; 2021 Jun; 22(8):1071-1078. PubMed ID: 33487043
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations.
    Baumer NT; Capone G
    Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32069. PubMed ID: 37870763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of mental health service use among Medicaid-insured youths treated by nurse practitioners and physicians: A retrospective cohort study.
    Yang BK; Idzik S; Evans P
    Int J Nurs Stud; 2021 Aug; 120():103956. PubMed ID: 34091256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic Medication Prescription Rates and Trends for New Zealand Children and Adolescents 2008-2016.
    Barczyk ZA; Rucklidge JJ; Eggleston M; Mulder RT
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):87-96. PubMed ID: 31633377
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
    Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
    J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Primary Care Providers' Consultations With a Statewide Child Psychiatry Access Program Regarding Autism Spectrum Disorder.
    Reinblatt SP; Coble K; Williams JL; Cotton AM; Bettencourt AF
    J Acad Consult Liaison Psychiatry; 2022; 63(5):463-473. PubMed ID: 35085823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
    Casseus M; Kim WJ; Horton DB
    Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.